32
Participants
Start Date
November 16, 2018
Primary Completion Date
May 27, 2019
Study Completion Date
June 3, 2019
P218 (1000 mg) Oral Capsules
1000 mg P218 (4 x 250 mg capsules)
Placebo Oral Capsules
Placebo capsules matched to the P218 capsules with regard to appearance and taste
P218 (100 mg) Oral Capsules
100 mg P218 (2 x 50 mg capsules)
PfSPZ Challenge
3200 P. falciparum Sporozoites by direct venous inoculation (DVI)
SGS Belgium NV Clinical Pharmacology Unit, Antwerp
Collaborators (1)
SGS Life Sciences, a division of SGS Belgium NV
OTHER
Institute of Tropical Medicine, Belgium
OTHER
Washington University School of Medicine
OTHER
Swiss BioQuant
INDUSTRY
PrimeVigilance Ltd., UK
INDUSTRY
Biologic LLP, UK
INDUSTRY
Sanaria Inc.
INDUSTRY
FGK Representative Service B.V., The Netherlands
INDUSTRY
Medicines for Malaria Venture
OTHER